In recent years, psychedelics have emerged as particularly promising in treating AUD. In this paper, we review trials of classic and non-classic psychedelics in the treatment of AUD to determine whether there is substantial evidence, either confirming or refuting the need for accompanying ...
Psychedelics psilocybin consciousness Do Clinical Trials Actually Help Cancer Patients Live Longer? June 19, 2024 Here's a provocative article that looks at something that you don't often see examined in enough detail: what are the benefits of clinical trials in oncology for the patients themselve...
We outline the atypical aspects of psychedelic clinical trials that support the case for introducingthe provision of PTA within research in this field, including the broader legal status of psychedelics, the nature of the researcher-therapist/participant relationship, and the extended time-frame of ...
Research Growing into the Use of Psychedelics to Treat Substance Abuse Don Tracy, Associate Editor August 29th 2024 A new National Institutes of Health grant will advance research into the role of the serotonin 5-HT2A receptor in mitigating methamphetamine use. ...
research as an option, it presents a path toward addressing the concerns of clinical trial access and participant diversity. However, this pathway will require the clinical research industry to provide support for the tools and mentorship needed to successfully conduct compliant clinical trials. ...
PhD JAMA Viewpoint State-Regulated Psychedelics on a Collision Course With FDA Mason Marks, MD, JD JAMA Correction Error in Byline JAMA Podcast (28:37) Psilocybin for Major Depressive Disorder 1x 0:00 / 0:00 Subscribe to Podcast Key Points Question What are the efficacy and safety of psilo...
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010;11(9):642-651. doi:10.1038/nrn2884 PubMedGoogle ScholarCrossref 15. Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264-355. doi:10.1124/pr.115.011478 ...
Novartis is looking to ligelizumab to defend the franchise, but with two phase 3 trials (PEARL 1 and PEARL 2) missing the mark, that hope has started to fade. CSU affects around 1% of the world's population and, in severe cases, causes debilitating symptoms that can last for weeks at...
Small Pharma is investigating the potential of psychedelics as a ”potentially revolutionary treatment” for depression and other mental health conditions and is exploring compounds — specifically DMT — to deliver solutions. This clinical trial is the world’s first formal trial to evaluate the combin...
Understand the effect of clinical trials and real-world evidence in healthcare on validating new treatments and providing proof of their effectiveness.